← All trials
NCT00988767
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2001
- Primary completion
- Nov 30, 2003
- Completion date
- Oct 31, 2004
- First posted
- Oct 2, 2009
- Last posted
- Oct 5, 2009
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institut National de la Santé Et de la Recherche Médicale, FranceLead sponsor
- University of ParisOverall official - principal investigator
- University of ParisOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.